Get started
Author

Tamara Nina Shenkier

Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency
2002 · Tamara N. Shenkier, Nicholas Voss, et al. · Journal of Clinical Oncology · 124
Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
2013 · Bryan P. Schneider, Robert J. Gray, et al. · Clinical Cancer Research · 57
Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: A cross-sectional analysis
1999 · S. Shariff, E.M. Yoshida, et al. · Annals of Oncology · 43
A Phase II Trial of a Neoadjuvant Platinum Regimen for Locally Advanced Breast Cancer: Pathologic Response, Long-Term Follow-up, and Correlation With Biomarkers
2009 · Rinat Yerushalmi, Malcolm M. Hayes, et al. · Clinical Breast Cancer · 15
Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC)
2008 · B. J. Klencke, S. Bhattacharya, et al. · Journal of Clinical Oncology · 12
Relationship between body mass index (BMI) at diagnosis of ER+ node negative breast cancer (BC) and Oncotype DX recurrence score.
2012 · Caroline A. Lohrisch, Ashley Davidson, et al. · Journal of Clinical Oncology · 4
A prospective clinical utility study of the impact of the 21-gene recurrence score assay (Oncotype DX) in estrogen receptor positive (ER+) node negative (pN0) breast cancer in academic Canadian centers.
2012 · James Ashley Davidson, Ian Cromwell, et al. · Journal of Clinical Oncology · 3
Virtual health in cancer care: Results from a semi-structured interview-survey of oncology health care providers.
2021 · Dan Le, Amanda Brain, et al. · Journal of Clinical Oncology · 2
Leveraging the power of diagnostic metrics to competency based medical education (CBME) implementation in medical oncology (MO) across Canada.
2025 · Anna T. Tomiak, Nazik Hammad, et al. · Journal of Clinical Oncology
Supplementary Tables 1 - 2 from Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
2023 · Bryan P. Schneider, Robert J. Gray, et al.
Data from Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
2023 · Bryan P. Schneider, Robert J. Gray, et al.
Supplementary Tables 1 - 2 from Prognostic and Predictive Value of Tumor Vascular Endothelial Growth Factor Gene Amplification in Metastatic Breast Cancer Treated with Paclitaxel with and without Bevacizumab; Results from ECOG 2100 Trial
2023 · Bryan P. Schneider, Robert J. Gray, et al.
PDF
A phase II trial of a neoadjuvant platinum-containing regimen for locally advanced breast cancer: Pathologic response, long-term follow-up, and correlation with biomarkers
2009 · T. N. Shenkier, M. Hayes, et al. · Journal of Clinical Oncology
Works count: 13
Citation count: 260
H-index: 5
I10-index: 5
Year
Topic
Type